This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Taisho Pharmaceutical Holdings Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Taisho Pharmaceutical Holdings has a total shareholder equity of ¥857.3B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥1,005.5B and ¥148.2B respectively. Taisho Pharmaceutical Holdings's EBIT is ¥18.9B making its interest coverage ratio -4. It has cash and short-term investments of ¥266.4B.
Informazioni chiave
0%
Rapporto debito/patrimonio netto
JP¥0
Debito
| Indice di copertura degli interessi | -4x |
| Contanti | JP¥266.37b |
| Patrimonio netto | JP¥857.30b |
| Totale passività | JP¥148.17b |
| Totale attività | JP¥1.01t |
Aggiornamenti recenti sulla salute finanziaria
Recent updates
Analisi della posizione finanziaria
Passività a breve termine: 4581's short term assets (¥416.8B) exceed its short term liabilities (¥80.8B).
Passività a lungo termine: 4581's short term assets (¥416.8B) exceed its long term liabilities (¥67.3B).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 4581 is debt free.
Riduzione del debito: 4581 has not had any debt for past 5 years.
Copertura del debito: 4581 has no debt, therefore it does not need to be covered by operating cash flow.
Copertura degli interessi: 4581 has no debt, therefore coverage of interest payments is not a concern.